Glenmede Trust CO Na Exact Sciences Corp Transaction History

Glenmede Trust CO Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $896 - $1,279	-9 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $27,707 - $46,096	-497 Reduced 98.22%	9 $0
Q4 2019 Feb 12, 2020	BUY	$77.66 - $99.74 $38,597 - $49,570	497 Added 5522.22%	506 $46,000
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $16,989 - $23,028	-188 Reduced 95.43%	9 $0
Q2 2019 Aug 13, 2019	BUY	$89.51 - $118.04 $16,559 - $21,837	185 Added 1541.67%	197 $23,000
Q1 2019 May 14, 2019	SELL	$61.98 - $96.5 $2,541 - $3,956	-41 Reduced 77.36%	12 $1,000
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $2,970 - $4,380	53 New	53 $3,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.